Pour certains hommes atteints d’un cancer de la prostate, le parcours de soins pourrait bientôt être considérablement allégé.
For many men with prostate cancer, the word “radiotherapy” still conjures up weeks of daily hospital trips: 20 or more ...
Prostate cancer is the most common cancer in Australia, with about 26,000 men diagnosed per year. The majority (more than 85%) are aged over 60. Prostate cancer kills around 3,900 Australians a year.
Fear of discomfort and unnecessary treatment often deters patients from prostate cancer screening, despite the benefits of early detection. Prostate cancer can be asymptomatic, making early detection ...
Hormone therapy initiation depends on disease extent; some agents avoid testosterone flare, allowing ADT without Casodex in certain cases. Active surveillance is increasingly chosen for favorable ...
In a population-based cohort study, a single prostate-specific antigen (PSA) measurement in men aged 45-70 years effectively identified individuals with low risk for cancer. Men with PSA levels < 1.00 ...
Un taux élevé de cet antigène peut être associé à un cancer sans en être spécifique. Après la publication d’une méta-analyse ...
A new means of prostate cancer screening could emerge as an alternative to the PSA test, which has long been the first-line option. Using machine learning, a form of artificial intelligence, Swedish ...
Editor's note: Dr. Jamin Brahmbhatt is a urologist and robotic surgeon with Orlando Health and an assistant professor at the University of Central Florida’s College of Medicine.When I learned that ...
Le cancer de la prostate reste le cancer le plus fréquent chez les hommes. De nouveaux chiffres le confirment, d’où ...
5don MSN
Cancer de la prostate : les activateurs de lymphocytes T « masqués », une immunothérapie prometteuse
Les premiers essais cliniques faisant appel à des immunothérapies appelées « activateurs de lymphocytes T masqués » ont fait ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results